Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

AbbVie reports phase IIIb head-to-head data on upadacitinib in atopic dermatitis

Dec. 11, 2020

Pharvaris discovers B2 bradykinin receptor antagonists

Dec. 11, 2020

Positive topline data presented from phase Ib study of EDP-1815 in atopic dermatitis

Dec. 10, 2020

Arcutis presents data from long-term safety study of ARQ-151 in plaque psoriasis

Dec. 3, 2020

Amgen initiates phase III study of ABP-654 in moderate to severe plaque psoriasis

Dec. 3, 2020

Preliminary week 18 phase Ib/IIa data reported for HST-001 in androgenic alopecia

Dec. 2, 2020

Integral Early Discovery, Integral Health Holdings discover ZRANB1 inhibitors

Dec. 1, 2020

Japan first to approve Humira for pyoderma gangrenosum

Nov. 30, 2020

European Commission approves Dupixent for severe atopic dermatitis in children aged 6-11 years

Nov. 30, 2020

Genfleet Therapeutics describes new RIPK1 inhibitors

Nov. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...